Name: Neuphoria Therapeutics Inc. (NEUP) Balance Sheet
Creator: FinSpry

Neuphoria Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Neuphoria Therapeutics Inc. (NEUP) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018
Current Assets
Cash and Cash Equivalents	14.21	0.01	0.01	0.02	0.03	0.00	0.01	0.03
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	14.21	0.01	0.01	0.02	0.03	0.00	0.01	0.03
Accounts Receivable	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.82	0.00	0.00	0.01	0.00	0.00	0.01	0.01
Total Current Assets	15.04	0.01	0.01	0.03	0.03	0.01	0.03	0.04
Non-Current Assets
Property, Plant & Equipment (Net)	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	8.64	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Intangible Assets	4.80	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	13.55	0.01	0.02	0.02	0.02	0.03	0.03	0.03
Total Assets	28.59	0.03	0.03	0.04	0.05	0.03	0.05	0.07
Current Liabilities
Accounts Payable	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Short-Term Debt	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	2.95	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Total Current Liabilities	4.22	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.02
Deferred Tax Liabilities	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	4.87	0.00	0.00	0.00	0.00	0.00	0.01	0.02
Total Non-Current Liabilities	5.37	0.00	0.00	0.00	0.00	0.01	0.02	0.03
Total Liabilities	9.59	0.01	0.01	0.01	0.01	0.02	0.04	0.05
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.15	0.14	0.00	0.00	0.00
Retained Earnings	-178.35	-0.18	-0.16	-0.12	-0.15	-0.15	-0.14	-0.13
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	0.00	0.20	0.19	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	0.00	0.20	1.47	1.35	1.01	0.00	0.00	0.00
Total Stockholders' Equity	19.00	0.02	0.02	0.04	0.05	0.01	0.02	0.02
Total Liabilities & Equity	28.59	0.03	0.03	0.04	0.05	0.03	0.05	0.07